Adam Shapiro
Primary Podiatric Medicine · Upland, CANPI 1669854089
Payments from drug & device makers
Across 358 payments — averaging $60.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$3K
- Integra Lifesciences Corporation$3K
- Medical Device Business Services, Inc.$3K
- Stryker$2K
- Paragon 28, Inc.$983
- Amgen$975
- plus $9K from 43 others
What the payments were for
- Travel & lodging$9,08842%
- Food & beverage$11,70954%
- Education$6923%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$3,380
- MOTOBAND$2,399
- PRIMATRIX$1,470
- INTEGRA DERMAL REGENERATION TEMPLATE$1,127
- SALVATION$867
- KRYSTEXXA$490
- FLOWTRIEVER CATHETER, S$461
- CT THROMBECTOMY SYSTEM KIT$461
- ACell$417
- NEURAGEN$417
- Qutenza$349
- BILAYER WOUND MATRIX (BWM)$343
- INTEGRA WOUND MATRIX (IWM)$343
- IDRT$343
- FLOWABLE$343
- Prokera$275
- AmnioGraft$275
- AmnioGuard$275
- Auryon Laser System 100-120 Vac$253
- Kimyrsa$250
How this compares
$21,488 in reported general payments places this provider in the 95th percentile of 59 primary podiatric medicine providers in California.
See all primary podiatric medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 12 | $1,665 |
| Cephalexin | 46 | $1,095 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 47 | $192 |
| Terbinafine Hcl | 24 | $184 |
| Clindamycin Hcl | 13 | $55 |
| Levofloxacin | 12 | $52 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Upland
- James WangLos Angeles$250K
- Abid ChaudhryArleta$81K
- Ali GhorbanifarajzadehBakersfield$17K
- Matthew GarrisonSacramento$7K
- Linh HuynhTurlock$7K
- Yvette CanabaSantee$5K
- David KhakshoorLos Angeles$4K
- Katrina SergeevaVista$4K
- Christyn MarshallDanville$3K
- Sloan GordonRancho Mirage$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.